A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence
出版年份 2016 全文链接
标题
A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence
作者
关键词
-
出版物
LEUKEMIA
Volume 31, Issue 4, Pages 896-902
出版商
Springer Nature
发表日期
2016-10-24
DOI
10.1038/leu.2016.300
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pomalidomide reverses -globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors
- (2015) B. M. Dulmovits et al. BLOOD
- Efficacy of ruxolitinib for myelofibrosis
- (2014) Fabio PS Santos et al. EXPERT OPINION ON PHARMACOTHERAPY
- Two cases of myelofibrosis with severe thrombocytopenia and symptomatology successfully treated with combination of pomalidomide and ruxolitinib
- (2014) Mirela Andrei et al. LEUKEMIA & LYMPHOMA
- Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management
- (2013) Ayalew Tefferi AMERICAN JOURNAL OF HEMATOLOGY
- Pomalidomide
- (2013) M. Q. Lacy et al. BLOOD
- Pomalidomide: First Global Approval
- (2013) Shelley Elkinson et al. DRUGS
- RBC-transfusion guidelines update
- (2012) R.P. Gale et al. LEUKEMIA RESEARCH
- International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-prednisone based regimens
- (2010) Prakash Thapaliya et al. AMERICAN JOURNAL OF HEMATOLOGY
- Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS
- (2010) C. Elena et al. HAEMATOLOGICA
- DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
- (2010) Naseema Gangat et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase-2 trial of low-dose pomalidomide in myelofibrosis
- (2010) K H Begna et al. LEUKEMIA
- MPN-associated myelofibrosis (MPN-MF)
- (2010) R.A. Mesa et al. LEUKEMIA RESEARCH
- What are RBC-transfusion-dependence and -independence?
- (2010) R.P. Gale et al. LEUKEMIA RESEARCH
- Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not
- (2009) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
- (2009) F. Passamonti et al. BLOOD
- Lenalidomide Plus Prednisone Results in Durable Clinical, Histopathologic, and Molecular Responses in Patients With Myelofibrosis
- (2009) Alfonso Quintás-Cardama et al. JOURNAL OF CLINICAL ONCOLOGY
- Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis
- (2009) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
- (2008) F. Cervantes et al. BLOOD
- Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells
- (2008) Laure A. Moutouh-de Parseval et al. JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now